Small miracles

WASHINGTON - The House Commerce Committee last week accomplished what Chairman Thomas Bliley called "a miracle", reaching an agreement on medical device labeling that had eluded the Senate's FDA reform efforts.

The committee passed three bills, H.R. 1411, which reauthorizes the Prescription Drug User Fee Act (PDUFA) and reforms regulation of drugs and biologics; H.R. 1710, the Medical Device Regulatory Modernization Act of 1997; and H.R. 2469,

Read the full 667 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE